GLP-1s support weight loss by: Delaying gastric emptying, which helps you feel fuller for longer after meals Regulating blood sugar, which can support steady energy and fewer cravings Reducing appetite and food noise by acting on hunger-regulating areas of the brain While Ozempic, Wegovy, Foundayo, and Zepbound all fall under the GLP-1 umbrella, Zepbound is unique in that it also targets another hormone called GIP (glucose-dependent insulinotropic polypeptide)
Long term health through optimal tissue repair and detoxification are impaired (3, 4)
The FDA said in a statement that compounding pharmacies would be given a grace period of 60 to 90 days, as was the case when Lilly's drugs were declared out of shortage
Subcutaneous injection delivers the peptide into the fatty tissue layer beneath the skin
For patients with Type 2 diabetes, for people whose endogenous GLP-1 signaling is impaired, they represent a meaningful advance